Home
Conditions
Recurrent Ovarian Epithelial Cancer

Clinical trial condition

Recurrent Ovarian Epithelial Cancer

Explore clinical trials studying Recurrent Ovarian Epithelial Cancer. Study availability and eligibility vary by location and protocol.

56 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Ovarian Epithelial Cancer trial results

Completed

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02122185

Conditions: Adnexal Diseases, Brenner Tumor, Carcinoma, +57 more
Locations: University of Alabama Birmingham, Alabama, United States

Mitchell Cancer Institute - University of South Alabama Mobile, Alabama, United States

City of Hope Duarte, California, United States

NCH Medical Group- Northwest Community Hospital Arlington Heights, Illinois, United States

View Trial Details

Completed

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00538031

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: City of Hope Duarte, California, United States

City of Hope Medical Group Inc Pasadena, California, United States

View Trial Details

Completed

Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

NCT01673217

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

NCT01536054

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +42 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

NCT01846520

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +137 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01747798

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00023712

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00041080

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +23 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer

NCT00053365

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00022659

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Recurrent Ovarian Epithelial Cancer

Recurrent Ovarian Epithelial Cancer trial results

Related conditions